Drug Research

The bio and pharma manufacturing industry happens to be an ever-growing as well as evolving landscape, wherein the emerging modalities and shifts in the field drive technological innovation. Advances within the field are clear to see from the approval...

Interestingly, one of the research projects by Root Analysis goes on to predict that pharmaceutical contract manufacturing market is all set to be valued at $140 billion by 2030. As such, the sector is most likely to grow at a...

Bora Pharmaceuticals Co., Ltd announced that it has completed the acquisition of Upsher-Smith  Laboratories, Inc. (“Upsher-Smith”), a generics manufacturer and marketer based in Minnesota, U.S.,  from its sellers, Sawai Group Holdings and Sumitomo Corporation of Americas. Upsher-Smith now is a...

The biopharmaceutical industry happens to be experiencing a massive shift toward continuous bioprocessing. Unlike traditional batch processing, which happens to be involving discrete stages with intermediate holding tanks, consistent bioprocessing operates seamlessly. Cells get grown, and the desired product...

In the modern era, biopharmaceutical discovery and development scientists happen to be achieving new levels when it comes to structural insight into therapeutic proteins. By way of utilizing biopharmaceutical analytical technology as well as mass spectrometry, laboratories happen to...

The 77th World Health Assembly- WHA goes on to mark the deadline for the conclusion of a pandemic agreement as well as amended International Health Regulations 2005 that look to make the planet much better prepared for the next...

Belgium-headquartered Exothera, a leading provider of nucleic acids and viral vector development and manufacturing services, has launched its game-changing nucleic acids service offering, powered by the world's first continuous-batch RNA production platform, Ntensify™. Developed by Exothera sister company Quantoom...